Archive/Invasiveness Study of Supersonic Gas-Curtain-Based Ionization Profile Monitor for Medical Accelerators
Invasiveness Study of Supersonic Gas-Curtain-Based Ionization Profile Monitor for Medical Accelerators
William Butcher, Narender Kumar, Milaan Patel et al.
30. Juni 2026
en

Abstract

In proton beam therapy, ideally, beam monitoring should be non-invasive to provide online real-time feedback, such that the total dose delivered to the patient is not significantly affected. The invasiveness of the Supersonic Gas-Curtain-Based Ionization Profile Monitor (SGC-IPM) system was quantified by perturbation in beam current and transverse beam profile parameters induced by the supersonic gas-curtain for a 4.9–5.3 keV electron beam, representing a worst-case scenario where perturbations can be more easily observable. The experimentally measured gas-curtain effects on transverse beam parameters (≤2%), intensity (≤−1%) and beam current (≤−1%) were small in magnitude and largely below resolution limits. To confirm these effects, order-of-magnitude beam–gas interaction approximations were calculated for the experimental energy range, demonstrating negligible energy loss with minor scattering, broadly consistent with the experimental results. Clinical proton beam gas-curtain predictions (70–250 MeV) indicate a further reduction of ∼104 compared to the experimental observations. Even under the conservative electron beam conditions used in this study, the observed perturbations were minor or unresolvable and measured effects were significantly smaller than spatial and dosimetry scales relevant to proton radiotherapy. Overall, the experimental measurements and supporting order-of-magnitude estimates demonstrate that the SGC-IPM introduces negligible perturbations to beam parameters and is predicted to provide non-invasive beam profile monitoring for clinical proton beam diagnostics.

IPC Classification

A61H01

Keywords

invasivenesssupersonicgas-curtain-basedionizationprofilemonitormedicalacceleratorsinstrumentsprotonbeamtherapyideallymonitoringshouldnon-invasiveprovideonlinereal-timefeedbacksuchtotaldosedelivered
Diese Veröffentlichung zitieren

€ 4.00